Tag: biosimilars billing
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
False Advertising in Generics: Legal Risks and Rules You Can't Ignore
Nov, 24 2025
Snovitra: Everything You Need to Know About This Erection Medication
Aug, 4 2025
Ocular Trauma: Chemical Splashes and Immediate First Aid
Dec, 28 2025
Arava: Exploring Israel’s Magical Desert Valley and Its Hidden Wonders
Jul, 3 2025
Chest Pain Evaluation: When to Go to the Emergency Department
Jan, 13 2026